TP Therapeutics Raises $45M

San Diego-based biopharmaceuticals firm TP Therapeutics announced this morning that it has raised $45M in a Series C funding round. Lilly Asia Ventures (LAV), OrbiMed Advisors, LLC, and S.R. One, Limited co-led the round, and also included Cormorant Asset Management and SV Tech Ventures. Hongbo Lu of Lilly Asia Ventures, and Simeon J. George of S.R. One both join the company's board as part of the funding. TP Therapeutics is developing treatments for patients with oncology drug resistance. More information »